Literature DB >> 12690042

Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases.

Stefan Kastenbauer1, Hans-Walter Pfister.   

Abstract

Studies on the incidence and spectrum of complications and prognostic factors in adults with pneumococcal meningitis are scarce. Therefore, we analysed 87 consecutive cases who were treated in our department between 1984 and 2002. Meningitis-associated intracranial complications developed in 74.7% and systemic complications in 37.9% of cases. Diffuse brain oedema (28.7%) and hydrocephalus (16.1%) developed more frequently than previously reported. The incidences of arterial (21.8%) and venous (9.2%) cerebrovascular complications were also very high. Furthermore, 9.2% of cases developed spontaneous intracranial haemorrhages (two patients with subarachnoid and two with subarachnoid and intracerebral bleedings, all in association with vasculitis; one subject with intracerebral haemorrhage due to sinus thrombosis; and three cases with intracerebral bleedings of unknown aetiology). Other new findings were the incidence of acute spinal cord dysfunction due to myelitis (2.3%) and that of hearing loss (19.5% of all patients and 25.8% of survivors). The in-hospital mortality was 24.1%. Only 48.3% of the patients had a good outcome at discharge [Glasgow Outcome Scale Score (GOS) = 5]. Outcome did not change during the study period, as mortality and GOS were similar for patients treated between 1984 and 1992 and for those treated between 1993 and 2002. Factors associated with a bad outcome (GOS </= 4) were chronic debilitating diseases, low Glasgow Coma Scale Score and focal neurological deficits on admission, low CSF leucocyte counts, pneumonia, bacteraemia and meningitis-associated intracranial and systemic complications. Low CSF leucocyte counts were also associated with the development of meningitis-associated intracranial complications. Age > or =60 years was associated with a higher mortality (36.7 versus 17.5%), but the GOS of the survivors was comparable to that of the surviving younger patients. The causes of death were mostly systemic complications in the elderly and cerebral complications in the younger patients. A haematogenous pathogenesis seemed likely in asplenic patients, while contiguous spread from sinusitis or otitis was the major cause of meningitis in non-asplenic individuals. Furthermore, asplenic patients had a raised incidence of meningitis-associated intracranial complications, but their outcome was similar to that of non-asplenic subjects. The morbidity and mortality of pneumococcal meningitis in adults are still devastating. We report higher incidences (diffuse brain swelling, hydrocephalus, cerebrovascular complications) or new incidences (myelitis, hearing loss, subarachnoid bleeding) of intracranial complications. Our detailed analysis of prognostic factors may help clinicians to identify patients at risk and may also be helpful in the design of clinical trials.

Entities:  

Mesh:

Year:  2003        PMID: 12690042     DOI: 10.1093/brain/awg113

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  118 in total

Review 1.  Bacterial meningitis: diagnosis and treatment.

Authors:  Russell D Snyder
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 5.081

Review 2.  Difficult and recurrent meningitis.

Authors:  L Ginsberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

3.  Pathophysiology and treatment of bacterial meningitis.

Authors:  Olaf Hoffman; R Joerg Weber
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

Review 4.  Development of adjunctive therapies for bacterial meningitis and lessons from knockout mice.

Authors:  Robert Paul; Uwe Koedel; Hans-Walter Pfister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

5.  Meningoencephalitis caused by Streptococcus pneumoniae: a diagnostic and therapeutic challenge. Diagnosis with diffusion-weighted MRI leading to treatment with corticosteroids.

Authors:  Philippe G Jorens; Paul M Parizel; Hendrik E Demey; Katrien Smets; Kris Jadoul; M M Verbeek; R A Wevers; Patrick Cras
Journal:  Neuroradiology       Date:  2005-09-07       Impact factor: 2.804

6.  Persisting vasculitis after pneumococcal meningitis.

Authors:  Deborah Pugin; Jean-Christophe Copin; Marie-Christelle Goodyear; Theodor Landis; Yvan Gasche
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

7.  Incidence and outcome of pneumococcal meningitis in northern England.

Authors:  N C Weightman; J Sajith
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

8.  Central nervous system vasculitis following pneumococcal meningitis.

Authors:  Todd Czartoski; Kyra Becker
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 9.  Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studies.

Authors:  Katelijne van de Vooren; Silvy Duranti; Alessandro Curto; Livio Garattini
Journal:  Pharmacoeconomics       Date:  2014-01       Impact factor: 4.981

10.  Delayed cerebral thrombosis in bacterial meningitis: a prospective cohort study.

Authors:  Marjolein J Lucas; Matthijs C Brouwer; Diederik van de Beek
Journal:  Intensive Care Med       Date:  2012-12-18       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.